Gene editing stocks are a game of pick-up-stick’s trading targets

July 25, 2018 12:22pm

CRSP (-$0.89 or -1.71%), EDIT (-$0.26 or -0.80%) and NTLA (+$0.14 or +0.49%) at Wednesday’s mid-day

Have “bottoms” been declared – not in their current DNA?

Maintaining SELL as there is more historical upside to “eat” through

CRISPR-Cas9 had been touted as the biotech discovery of the century. CRISPR-Cas9 might have potential, but still comes with huge risks!

Editas Medicine (EDIT) closed at $32.46 and opened at $32.41 in a morning range of $32.17 to $33.54

• The stock's 50-day moving average of $37.37 is above its 200-day moving average of $35.70.
• Volume at the mid-day was 408.2 K shares traded <3 month average = 1.007 M shares>;
• The 52 week high was $45.02 and the low is $15.28;
• Shares outstanding are 46.68 M and the float is 41.87;
• Shares of EDIT are up 99.02% year-to-date;
• Shares short (as of 6/14) of float is 11.38% or 5.14 M, down from May’s 5.88 M

CRIPR Therapeutics (CRSP) closed at $51.81 and opened at $50.91 in a morning range of $50.00 to $53.15

• The stock's 50-day moving average of $61.66 is above its 200-day moving average of $51.36.
• Volume at the mid-day was 502.78 K shares traded <3 month average = 1.59 M shares>;
• The 52 week high was $73.90 and the low is $16.16;
• Shares outstanding are 47.19 M and the float is 25.81 M;
• Shares of CRSP are up 196.53% year-to-date;
• Shares short (as of 6/14) of float is 11.65% or 3.45 M, up from May’s 2.81M

Intellia (NTLA) closed at $28.49 and opened at $28.37 in a morning range of $28.37 to $29.91

• The stock's 50-day moving average of $28.98 is above its 200-day moving average of $25.21;
• Volume at the mid-day was 297.1 K <3 month average = 919.7 K shares>;
• Shares outstanding are 43.09 and the float is 30.75;
• The 52 week range is $14.45 with a high is $35.99;
• Shares of NTLA are up 68.48% year-to-date;
• Shares short of float (as of 6/14) are 4.9 M shares or 13.52%

Gene “editors” have focused mostly on the ability to cut DNA; they should be paying attention to the potential of after effects!

Reiterating, “Would you bet your life and your current portfolio on a mouse model; it’s always a game of “truth or consequences”.

See you in the trading “sand box”!